In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, INmune Bio Inc’s stock clocked out at $1.86, down -6.06% from its previous closing price of $1.98. In other words, the price has decreased by -$6.06 from its previous closing price. On the day, 0.55 million shares were traded. INMB stock price reached its highest trading level at $1.9843 during the session, while it also had its lowest trading level at $1.85.
Ratios:
To gain a deeper understanding of INMB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.20 and its Current Ratio is at 4.20. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On January 28, 2025, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $23.Rodman & Renshaw initiated its Buy rating on January 28, 2025, with a $23 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INMB now has a Market Capitalization of 49448580 and an Enterprise Value of 16525580. For the stock, the TTM Price-to-Sale (P/S) ratio is 989.00 while its Price-to-Book (P/B) ratio in mrq is 1.71. Its current Enterprise Value per Revenue stands at 330.512.
Stock Price History:
The Beta on a monthly basis for INMB is 0.97, which has changed by -0.63385826 over the last 52 weeks, in comparison to a change of 0.118204355 over the same period for the S&P500. Over the past 52 weeks, INMB has reached a high of $11.64, while it has fallen to a 52-week low of $1.71. The 50-Day Moving Average of the stock is -14.23%, while the 200-Day Moving Average is calculated to be -66.84%.
Shares Statistics:
It appears that INMB traded 1.47M shares on average per day over the past three months and 399790 shares per day over the past ten days. A total of 26.59M shares are outstanding, with a floating share count of 18.90M. Insiders hold about 28.90% of the company’s shares, while institutions hold 21.23% stake in the company. Shares short for INMB as of 1759190400 were 3279355 with a Short Ratio of 2.23, compared to 1756425600 on 3738496. Therefore, it implies a Short% of Shares Outstanding of 3279355 and a Short% of Float of 14.860000000000001.
Earnings Estimates
Its stock is currently analyzed by 2.0 different market analysts. The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.31 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.22 and -$1.59 for the fiscal current year, implying an average EPS of -$1.44. EPS for the following year is -$1.14, with 4.0 analysts recommending between -$0.72 and -$1.3.
